Skip to main content
. 2016 Jul 25;16:11. doi: 10.1186/s12895-016-0048-z

Fig. 5.

Fig. 5

Change from baseline in percent BSA involvement of psoriasis at each visit. ANCOVA, analysis of covariance; ACT, acitretin; BSA, body surface area; ETN, etanercept. *p < 0.05; **p < 0.005 (treatment difference tested by ANCOVA)